PWM
WST icon

Perigon Wealth Management’s West Pharmaceutical WST Stock Holding History

Perigon Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Buy
1,868
+286
+18% +$87.4K 0.01% 747
2026
Q1 		$397K Sell
1,582
-449
-22% -$112K 0.01% 907
2025
Q4 		$559K Buy
2,031
+423
+26% +$116K 0.01% 741
2025
Q3 		$422K Buy
1,608
+422
+36% +$103K 0.01% 811
2025
Q2 		$259K Sell
1,186
-497
-30% -$106K 0.01% 897
2025
Q1 		$377K Sell
1,683
-25
-1% -$6.89K 0.01% 729
2024
Q4 		$576K Sell
1,708
-42
-2% -$13.2K 0.01% 595
2024
Q3 		$525K Buy
+1,750
New +$536K 0.01% 606
2024
Q1 		– Sell
-1,863
Closed -$656K – 926
2023
Q4 		$656K Sell
1,863
-15
-0.8% -$5.31K 0.02% 431
2023
Q3 		$705K Sell
1,878
-20
-1% -$7.73K 0.03% 375
2023
Q2 		$726K Buy
1,898
+23
+1% +$8.22K 0.03% 372
2023
Q1 		$650K Buy
1,875
+48
+3% +$14K 0.04% 346
2022
Q4 		$430K Buy
+1,827
New +$433K 0.03% 419
2022
Q2 		– Sell
-668
Closed -$274K – 628
2022
Q1 		$274K Buy
668
+156
+30% +$61.1K 0.02% 489
2021
Q4 		$240K Buy
+512
New +$220K 0.02% 510
2021
Q1 		– Sell
-95
Closed -$27K – 1041
2020
Q4 		$27K Buy
+95
New +$26.7K ﹤0.01% 943

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Perigon Wealth Management's WST Position: Q2 2026 in Review

Perigon Wealth Management increased its West Pharmaceutical (WST) stake by 18% in Q2 2026, buying an estimated $87.4K and bringing the position to 1,868 shares worth $671K. The position accounts for 0.01% of the portfolio, ranked #747.

Perigon Wealth Management first reported a position in WST in Q4 2020 and has held it in 16 quarters since. The position peaked at $726K in Q2 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Perigon Wealth Management held 1,868 shares of West Pharmaceutical worth $671K as of Q2 2026.
  • Perigon Wealth Management bought 286 West Pharmaceutical shares in Q2 2026, an estimated $87.4K.
  • West Pharmaceutical made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #747 holding.
  • Perigon Wealth Management first reported a position in West Pharmaceutical in Q4 2020 and has held it in 16 quarters since.
  • Perigon Wealth Management's West Pharmaceutical position peaked at $726K in Q2 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.